AU644621B2 - Pharmaceutical composition for treating or preventing retroviral infections - Google Patents

Pharmaceutical composition for treating or preventing retroviral infections

Info

Publication number
AU644621B2
AU644621B2 AU69755/91A AU6975590A AU644621B2 AU 644621 B2 AU644621 B2 AU 644621B2 AU 69755/91 A AU69755/91 A AU 69755/91A AU 6975590 A AU6975590 A AU 6975590A AU 644621 B2 AU644621 B2 AU 644621B2
Authority
AU
Australia
Prior art keywords
treating
pharmaceutical composition
retroviral infections
preventing retroviral
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU69755/91A
Inventor
Bruno Guy
Jean-Pierre Lecocq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9013102A external-priority patent/FR2668065B1/en
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of AU644621B2 publication Critical patent/AU644621B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A pharmaceutical composition for treating or preventing retroviral diseases containing a thiol-protease inhibitor as an active principle. Thiol-protease inhibitors are known products such as cystatines and the derivatives thereof, antipaine [(S)-1-carboxy-2-phenyletyl]-carbamoyl-Arg-Val-Arg-al, E-64 (L-trans-epoxysuccinyl-leucylamide-(4-guanidino)-butane, N-[N-(L-3-transcarboxyirane-2-carbonyl)-L-leucyl]-agmatine, leupeptin, iodoacetic acid/iodoacetamide or N-Cbz-Phe-Ala-diazomethane.
AU69755/91A 1989-12-18 1990-12-18 Pharmaceutical composition for treating or preventing retroviral infections Ceased AU644621B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR8916726 1989-12-18
FR8916726 1989-12-18
FR9013102A FR2668065B1 (en) 1990-10-23 1990-10-23 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF RETROVIRAL INFECTIONS.
FR9013102 1990-10-23
PCT/FR1990/000921 WO1991008769A1 (en) 1989-12-18 1990-12-18 Pharmaceutical composition for treating or preventing retroviral infections

Publications (1)

Publication Number Publication Date
AU644621B2 true AU644621B2 (en) 1993-12-16

Family

ID=26227737

Family Applications (2)

Application Number Title Priority Date Filing Date
AU69755/91A Ceased AU644621B2 (en) 1989-12-18 1990-12-18 Pharmaceutical composition for treating or preventing retroviral infections
AU69755/91A Granted AU6975591A (en) 1989-12-18 1990-12-18 Pharmaceutical composition for treating or preventing retroviral infections

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU69755/91A Granted AU6975591A (en) 1989-12-18 1990-12-18 Pharmaceutical composition for treating or preventing retroviral infections

Country Status (8)

Country Link
EP (1) EP0506769B1 (en)
JP (1) JPH05502868A (en)
AT (1) ATE109006T1 (en)
AU (2) AU644621B2 (en)
CA (1) CA2071972A1 (en)
DE (1) DE69011130T2 (en)
DK (1) DK0506769T3 (en)
WO (1) WO1991008769A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3604093A (en) * 1992-02-07 1993-09-03 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of 5,5'-dithio-bis(2-nitrobenzoic acid) for inhibition of HIV protease
RU2126794C1 (en) * 1992-03-11 1999-02-27 Нархекс Лимитед Amino-derivatives of oxo- or hydroxy-substituted hydrazines, method of their synthesis and pharmaceutical compositions for inhibition of retrovirus protease
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
ATE253050T1 (en) 1992-03-11 2003-11-15 Narhex Ltd AMINE DERIVATIVES OF OXO- AND HYDROXY-SUBSTITUTED HYDROCARBONS
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
SK281127B6 (en) * 1992-09-09 2000-12-11 Amgen Inc. Use of serine leukocyte protease inhibitor
FR2778851B1 (en) * 1998-05-19 2002-07-26 Aetsrn COMPOSITION BASED ON CYSTEINE PROTEASE INHIBITORS FOR DELAYING SENESCENCE, SELF-DESTRUCTION AND HEMOLYSIS OF ERYTHROCYTES
WO2005011649A2 (en) * 2003-05-19 2005-02-10 Vanderbilt University Methods of treating severe acute respiratory syndrome virus infections
WO2006091610A2 (en) * 2005-02-23 2006-08-31 The Brigham And Women's Hospital, Inc. Inhibitors of enveloped virus infectivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8510058A8 (en) * 1985-01-16 1996-04-30 Inst Jozef Stefan P O Process for insulation of poultry egg's cystatine from egg-white
EP0269311A3 (en) * 1986-11-17 1990-06-06 Merck & Co. Inc. Methods of treating bone diseases by administration of a cysteine proteinase inhibitor

Also Published As

Publication number Publication date
WO1991008769A1 (en) 1991-06-27
JPH05502868A (en) 1993-05-20
EP0506769A1 (en) 1992-10-07
CA2071972A1 (en) 1991-06-19
DE69011130T2 (en) 1995-03-16
DE69011130D1 (en) 1994-09-01
ATE109006T1 (en) 1994-08-15
DK0506769T3 (en) 1994-11-28
AU6975591A (en) 1991-07-18
EP0506769B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
ES2145913T3 (en) METALOPROTEASE INHIBITORS.
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
EP1452172A3 (en) Multiple unit pharmaceutical preparation
EP1210941A3 (en) Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS
WO1995009619A3 (en) Substituted urea and isothiourea derivatives as no synthase inhibitors
ZA881764B (en) Thiazole derivatives active on the cholinerigic system,process for obtention and pharmaceutical compositions
FI903153A0 (en) 11B-ARYL-4-ESTRENER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT DERAS ANVAENDNING SOM LAEKEMEDEL.
ES2045182T3 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCESS FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
AU644621B2 (en) Pharmaceutical composition for treating or preventing retroviral infections
IL95391A0 (en) Substituted n-(quinolin-2-yl-methoxy)benzyl-sulphonyl-ureas,their preparation and pharmaceutical compositions containing them
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
AU7125991A (en) Novel antiulcer substance
WO2001049309A3 (en) Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue
PT989994E (en) STREPTOGRAMINE DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS THAT CONTAIN THEM
EP0386920A3 (en) 2-hydroxy-3-thienyloxypropylamino derivatives
IE831551L (en) Eye ointment.
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
AU8744691A (en) N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
IL89126A0 (en) Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them
GT199400048A (en) PHARMACEUTICAL COMPOSITION AND PROCESS FOR ITS PREPARATION
AU6991291A (en) 3-l-(5-thioxo-l-prolyl) thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them
NO883066L (en) NEW STEROID CONNECTIONS, FERTILIZATION PREVENTION CONTAINING THE COMPOUNDS AS ACTIVE INGREDIENT AND USE OF THE COMPOUNDS FOR AA PREVENTION.